RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 111 filers reported holding RAPT THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.65 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $31,921,336 | -25.4% | 1,920,658 | -16.1% | 1.06% | -14.0% |
Q2 2023 | $42,794,819 | +1.8% | 2,288,493 | -0.1% | 1.24% | -0.2% |
Q1 2023 | $42,051,007 | +18.1% | 2,291,608 | +27.4% | 1.24% | +24.2% |
Q4 2022 | $35,619,309 | -13.6% | 1,798,955 | +5.0% | 1.00% | -16.4% |
Q3 2022 | $41,218,000 | +18.0% | 1,713,134 | -10.5% | 1.20% | +9.3% |
Q2 2022 | $34,927,000 | -43.3% | 1,913,791 | -31.6% | 1.09% | -11.3% |
Q1 2022 | $61,571,000 | -71.4% | 2,799,962 | -52.2% | 1.23% | -25.7% |
Q4 2021 | $215,058,000 | +138.2% | 5,855,130 | +101.4% | 1.66% | +26.5% |
Q3 2021 | $90,280,000 | -42.7% | 2,907,565 | -42.3% | 1.31% | +28.2% |
Q2 2021 | $157,568,000 | +186.5% | 5,041,320 | +103.5% | 1.02% | +47.0% |
Q1 2021 | $55,000,000 | +76.5% | 2,477,481 | +57.1% | 0.70% | +108.4% |
Q4 2020 | $31,155,000 | – | 1,577,481 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Column Group LLC | 2,680,621 | $44,551,921 | 29.58% |
GREAT POINT PARTNERS LLC | 1,458,070 | $24,233,123 | 4.41% |
Euclidean Capital LLC | 1,315,798 | $21,868,562 | 2.39% |
Trustees of Columbia University in the City of New York | 73,383 | $1,219,625 | 2.24% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 805,828 | $13,392,861 | 1.54% |
Perceptive Advisors | 1,920,658 | $31,921,336 | 1.06% |
Deep Track Capital, LP | 1,500,000 | $24,930,000 | 0.96% |
Cheyne Capital Management (UK) LLP | 20,000 | $332,400 | 0.96% |
Alphabet Inc. | 540,270 | $8,979,287 | 0.58% |
BRAIDWELL LP | 1,082,512 | $17,991,349 | 0.57% |